SIPA1L2: A Potential Drug Target and Biomarker forSPA-1-Like 2-Induced Neural Mourning

Target Name: SIPA1L2

NCBI ID: G57568

SIPA1L2

SIPA1L2: A Potential Drug Target and Biomarker forSPA-1-Like 2-Induced Neural Mourning

SPA-1-like 2 (SIPA-1-like 2) is a protein that has been shown to interact with multiple G protein-coupled receptors, including GPRCz, GPRCa, and GPRCb. It has been identified as a potential drug target in the treatment of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and neurodegenerative diseases.

SIPA-1-like 2 is a member of the SIPA family, which includes several related proteins that have been shown to play important roles in neurotransmission. The SIPA family proteins are involved in the regulation of neurotransmitter release from axons and dendrites, as well as in the modulation of neuronal excitability.

SIPA-1-like 2 has been shown to interact with several G protein-coupled receptors, including GPRCz, GPRCa, and GPRCb. G protein-coupled receptors are a family of transmembrane proteins that play a critical role in intracellular signaling. They are composed of a catalytic subunit that binds to a G protein, a catalytic subunit that reacts with the G protein, and a transmembrane subunit that interacts with other components of the cell.

SIPA-1-like 2 has been shown to regulate the release of several neurotransmitters, including GABA, dopamine, and nitric oxide. It has been shown to inhibit the activity of several G protein-coupled receptors, including GPRCz, GPRCa, and GPRCb. These effects on neurotransmission are consistent with the role of SIPA-1-like 2 as a potential drug target for neurological disorders.

SIPA-1-like 2 has also been shown to play a role in the regulation of neuronal excitability. It has been shown to modulate the activity of several ion channels, including the potassium channel and the calcium channel. These effects on neuronal excitability are consistent with the role of SIPA-1-like 2 as a potential biomarker for neurological disorders.

In conclusion, SIPA-1-like 2 is a protein that has been shown to interact with multiple G protein-coupled receptors and to play important roles in neurotransmission and neuronal excitability. Its potential as a drug target and biomarker make it an attractive target for the development of new treatments for neurological disorders. Further research is needed to fully understand the role of SIPA-1-like 2 in neurological disease and to develop effective treatments.

Protein Name: Signal Induced Proliferation Associated 1 Like 2

The "SIPA1L2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SIPA1L2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets